Raed Dweik, MD

Raed Dweik, MD, MBA is the Inaugural Chief of the Integrated Hospital Care Institute (IHI) at the Cleveland Clinic Health System (CCHS) which is home to over 4,000 caregivers and a faculty of over 1,200 physicians and scientists in Ohio, Florida, London, and Abu-Dhabi. As Institute Chief, Dr. Dweik is responsible for setting the strategic direction and the day-to-day operations of the Institute in all areas of clinical care, education, research, and innovation.

The Integrated Hospital Care Institute (IHI) at the Cleveland Clinic is a unique model that does not exist elsewhere in healthcare. IHI brings hospital-based services under one umbrella by bringing together 5 Departments (Emergency Services, Hospital Medicine, Pulmonary-Critical Care, Infectious Disease, and Anesthesiology) that are home to 12 divisions. The Institute also has 2 Centers (Critical Care and Perioperative Medicine) designed to organize the clinical, education, and research activities of these services across the entire Cleveland Clinic Health System. The leaders, providers, educators, researchers, and caregivers of IHI work collaboratively with hospitals across geographies to innovate and reimagine the patient journey as we provide seamless access to our high-quality care and cutting-edge research to more patients in more locations in the United States and around the globe. Graduate medical education programs in IHI include over 150 residents and over 100 fellows in 14 specialties and subspecialties in addition to an APP-CRNA School and APP-ICU Fellowship. We conduct research activities across the spectrum of basic, translational, and clinical research with over 650 IRB-approved projects supported by over 100 federal grants, 150 industry sponsored trials, and various foundation awards.

Dr. Dweik's clinical interests include pulmonary hypertension, asthma, chronic beryllium disease and critical care and he regularly attends in the medical intensive care unit (MICU). He is board certified in internal medicine, pulmonary disease and critical care medicine and has been listed in The Best Doctors in America since 2005.

Dr. Dweik is Professor of Medicine at Cleveland Clinic Lerner College of Medicine and has a joint appointment in the Lerner Research Institute (LRI) with continuous funding from the NIH since 2002. He established a Research Center of Excellence in Pulmonary Vascular Disease including a patient registry, a human sample biorepository and an animal model core. He was the recipient of the Cleveland Clinic Outstanding Innovation in Translational Medicine Award and a Third Frontier Award from the state of Ohio for his pioneering work in exhaled breath analysis in lung and systemic disease. He has published over 250 peer reviewed manuscripts and book chapters and serves on several journal editorial boards, National Institutes of Health (NIH) review panels and American Thoracic Society (ATS), American Heart Association (AHA), and Association of American Medical Colleges (AAMC) committees.

Dr. Dweik is the recipient of many teaching awards including the Cleveland Clinic Distinguished Teacher Award from the Internal Medicine Residency Program for five times, the Teacher of the Year Award from the Pulmonary Fellowship Program and the Scholarship in Teaching Award from Case Western Reserve University. He is Director of the KL2 program of the Cleveland Clinical and Translational Science Collaborative (CTSC), a member of the admissions committee at CCLCM, and past chair of the Committee on Advancement, Promotion and Tenure (CAPT) at Case Western Reserve University School of Medicine.

Dr. Dweik has served on the Board of Governors, Board of Trustees and Board of Directors of the Cleveland Clinic Health System and chairs the system's Innovation Management and Conflict of Interest committee (IM&COI), the routine Capital Review Committee (CRC) and the strategic capital Advisory Team (AT).

Dr. Dweik is a Fellow of the American College of Physicians (FACP), the Royal College of Physicians of Canada (FRCPC), the American College of Chest Physicians (FCCP), the Society of Critical Care Medicine (FCCM), the American Thoracic Society (ATSF), the American Heart Association (FAHA), the Pulmonary Vascular Research Institute (PVRI), and a founding member of the International Association for Breath Research (IABR).

After receiving his medical degree from the University of Jordan Faculty of Medicine, Dr. Dweik completed his internship and residency in internal medicine at Miami Valley Hospital and Wright State University in Dayton, OH. He completed his fellowship in pulmonary and critical care medicine at Cleveland Clinic. He earned an MBA from Case Western Reserve University in 2017.

Education & Professional Highlights

Appointed
1993

Education & Fellowships

Graduate School - Case Western Reserve University Weatherhead School of Management
MBA
Cleveland, OH USA
2017

Fellowship - Cleveland Clinic
Pulmonary Disease/Critical Car
Cleveland, OH USA
1996

Residency - Wright State University
Internal Medicine
Dayton, OH USA
1993

Internship - Miami Valley Hospital
Internal Medicine
Dayton, OH USA
1990

Internship - Jordan University Hospital
Rotating
Amman,
1989

Medical Education - University of Jordan Faculty of Medicine
Amman, Jordan
1988

Additional Training

Professional Highlights

Executive:
2024- Member, Enterprise Board of Governors, Cleveland Clinic
2024- Member, Enterprise Management Council, Cleveland Clinic
2023- Chief, Integrated Hospital Care Institute (IHI), Cleveland Clinic
2018-2023 Chair, Respiratory Institute (RI), Cleveland Clinic
2015 Member, Cleveland Clinic Board of Directors Cleveland Clinic, Cleveland, OH
2014-15 Member, Cleveland Clinic Board of Trustees Cleveland Clinic, Cleveland, OH
2014-2022 Chair, Innovation Management and Conflict of Interest, Cleveland Clinic Health System
2011-15 Elected member: Cleveland Clinic Board of Governors
2008-2013 Member, Respiratory Institute Executive Physician Committee
2008-2013 Member, Respiratory Institute Administrative Council, Cleveland Clinic
Clinical and Academic:
2023- Elected secretary of the American Thoracic Society (President in 2025)
2016-2020 Chair, Documents Development and implementation Committee (DDIC), American Thoracic Society (ATS)
2014-2024 Director, KL2 Program and Chair, KL2 Steering Committee / Cleveland Clinical and Translational Science Collaborative (CTSC), Case Western Reserve University SOM
2014-15 Chair, Committee on Appointment, Promotion, and Tenure (CAPT), Case Western Reserve University School of Medicine (CWRU-SOM)
2014-2022 Chair, Cleveland Clinic Standing Committee on Research Conduct and Quality
2015 Chair, Cardiorenal and Lung Peer Review Committee, American Heart Association (AHA)
2015-2019 Reviewer, Respiratory Integrative Biology and Translational Research, RIBT Study section, National Heart Lung and Blood Institute (NHLBI) - NIH
2009-2016 Scientific Advisory Board (SAB) Member: Mid-Infrared Technologies for Health and the Environment, A National Science Foundation (NSF) – Engineering Research Center at Princeton University and Partners
2008-2012: Third Frontier Award: Ohio Department of Development
2005- Founding Member: International Association for Breath Research (IABR)
2005-2010 Member / Reviewer, Special Emphasis Panel, Mentored Clinical Scientist Development Award (K08), National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH)
2004- 2009 Member, Special Emphasis Panel, Mentored Patient Oriented Research Career Development Awards (K18, K23, K24 and K25) National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH)
2003-2018 Admissions Committee Member, Cleveland Clinic Lerner College of Medicine of CWRU

Certifications

Internal Medicine - Critical Care Medicine
Internal Medicine
Internal Medicine - Pulmonary Disease

Specialty Interests

Pulmonary hypertension, pulmonary vascular disease, asthma, beryllium disease, chronic beryllium disease, berylliosis, respiratory failure, ARDS, sepsis

Awards & Honors

Listed in "Best Doctors in America": 2005- Present
Distinguished Teacher Award Internal Medicine Residency Program: 2000-01, 2003-04, 2004-05, 2006-07, 2007-08.
Teacher of the Year Award Pulmonary Fellowship Program: 2006-2007
Cleveland Clinic Foundation Innovator Award 2004
Lerner Research Institute STAR Award 2010

Innovations & Patents

Exhaled Breath Testing

Memberships

American College of Physicians, Fellow (FACP)
American College of Chest Physicians, Fellow (FCCP)
Royal College of Physicians of Canada, Fellow (FRCPC)
American Heart Association (AHA), Fellow (FAHA)
Society of Critical Care Medicine (SCCM), Fellow (FCCM)
Pulmonary Vascular Research Institute (PVRI), Fellow
American Thoracic Society (ATS), Fellow (ATSF)
International Association for Breath Research, Founding Member

Research & Publications

See publications for Raed Dweik, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/17/2023, Dr. Dweik has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Dweik receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

BreathTech Corporation

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Dweik may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

BreathTech Corporation

Fiduciary Role. Dr. Dweik serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

American Thoracic Society, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Coming to a Cleveland Clinic location?

Primary Location

Cleveland Clinic London-24 PP (MOB)

Additional Locations

Treatment & Services

Specialty in Diseases & Conditions

Insurance

Is Cleveland Clinic Part of Your Insurance?